Intra-Cellular’s clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.

She was admitted for a six-week stay and given diagnoses she knew were wrong: an eating disorder and anxiety. Read More: Long ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed ...

The most commonly prescribed drug, methylphenidate, can cost private patients between £15 and £50 per month. Whilst ...

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

Experts say there’s been a rise in young people taking 'Xanax' recreationally in Australia. The drug is usually prescribed to ...

The most common and incorrect presentation of OCD in media is conflating the disorder with being a “neat freak” or a ...

A with psychiatry and behavioral sciences professor Alik Widge, a lead author of the University of Minnesota study.

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

The fireside chat will be held at the ABHI UK Pavilion, Arab Health 2025, on Monday, 27th January, from 3-4pm (local time).

Sir Tony Blair said there is a danger of telling too many people going through life's normal challenges that they are ...

Zane Gonzalez spent three years out of football. On Sunday, he sank a buzzer-beating field goal to push the Commanders to the ...